<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03683290</url>
  </required_header>
  <id_info>
    <org_study_id>oocyte_imaging_2018</org_study_id>
    <nct_id>NCT03683290</nct_id>
  </id_info>
  <brief_title>Modulation Contrast Microscopy Imaging for Oocyte Quality Assessment</brief_title>
  <official_title>Efficiency of Modulation Contrast Microscopy Image Analysis as a Predictive Tool for Human Oocyte Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Reproductive an Genetic Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Center for Reproductive an Genetic Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims to describe novel non-invasive parameters related to the competence of
      female reproductive cells (oocytes). In a fertility unit, human reproductive cells and
      embryos are subjected to different imaging technologies. Images can easily be obtained
      without disturbing the microenvironment during different standard procedures. Turning images
      into quantifiable data might provide a further understanding on oocyte behavior and
      performance in the laboratory.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>40 Weeks</target_duration>
  <primary_outcome>
    <measure>Implantation</measure>
    <time_frame>6 weeks gestation</time_frame>
    <description>Number of gestational sacs seen on ultrasound scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live Birth</measure>
    <time_frame>40 weeks gestation</time_frame>
    <description>Baby to be born after embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilisation</measure>
    <time_frame>17 ± 1 hours post insemination</time_frame>
    <description>Appearance of two pronucleii after insemination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality clevage</measure>
    <time_frame>68 ± 1 hours post insemination</time_frame>
    <description>Quality after three days of culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality Blastocyst</measure>
    <time_frame>116 ±2 hours post insemination</time_frame>
    <description>Quality at the blastocyst stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euploidy</measure>
    <time_frame>2-3 weeks post insemination</time_frame>
    <description>Number of chromosomes (if available, after PGT-A)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nuclear maturity</measure>
    <time_frame>36-41 post hCG</time_frame>
    <description>Presence of meiotic spindle (if available, PolScope)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Oocyte Competence</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Image acquisition and analysis</intervention_name>
    <description>Oocyte image obtention and analysis prior to intracytoplasmic sperm injection</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Registered patients at The Centre for Reproductive and Genetic Health
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intracytoplasmic sperm injection

          -  Embryo culture with subsequent fresh embryo transfer

        Exclusion Criteria:

        - Conventional IVF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sioban SenGupta</last_name>
    <role>Study Chair</role>
    <affiliation>Institute for Women's Health (UCL)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Vinals Gonzalez, MSc</last_name>
    <phone>02078372905</phone>
    <email>xavier.vinalsgonzalez@crgh.co.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Reproductive and Genetics Health</name>
      <address>
        <city>London</city>
        <zip>W1W 5QS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Vinals Gonzalez</last_name>
      <phone>02078372905</phone>
      <email>xavier.vinalsgonzalez@crgh.co.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center for Reproductive an Genetic Health</investigator_affiliation>
    <investigator_full_name>Xavier Vinals Gonzalez</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Oocyte</keyword>
  <keyword>Embryo</keyword>
  <keyword>Development</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Competence</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be collected and analysed internally. Results will be available (if published) in a scientific journal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

